Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Piazza

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biotechnology Advances|June 14, 2011
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonistsFrancesco Peri, Matteo Piazza
Studies in Health Technology and Informatics|April 28, 2005
Context-based task ontologies for clinical guidelinesAnand Kumar, Paolo Ciccarese, Barry Smith, et al.
Studies in Health Technology and Informatics|September 14, 2004
Cognitive human factors for telemedicine systemsMatteo Piazza, Toni Giorgino, Ivano Azzini, et al.
Biochemical Society Transactions|September 25, 2010
Exploring the LPS/TLR4 signal pathway with small moleculesFrancesco Peri, Matteo Piazza, Valentina Calabrese, et al.
Biochemical Pharmacology|July 6, 2010
The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 bindingMatteo Piazza, Valentina Calabrese, Chiara Baruffa, et al.
Biochemistry|November 26, 2009
Evidence of a specific interaction between new synthetic antisepsis agents and CD14Matteo Piazza, Liping Yu, Athmane Teghanemt, et al.
Innate Immunity|May 18, 2010
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targetsMatteo Piazza, Gaetana Damore, Barbara Costa, et al.
Journal of Medicinal Chemistry|January 24, 2009
Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterizationMatteo Piazza, Clara Rossini, Silvia Della Fiorentina, et al.
Chemical Biology & Drug Design|February 21, 2016
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological PropertiesCarlotta Ciaramelli, Valentina Calabrese, Stefania E Sestito, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biotechnology Advances|June 14, 2011
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonistsFrancesco Peri, Matteo Piazza
Studies in Health Technology and Informatics|April 28, 2005
Context-based task ontologies for clinical guidelinesAnand Kumar, Paolo Ciccarese, Barry Smith, et al.
Studies in Health Technology and Informatics|September 14, 2004
Cognitive human factors for telemedicine systemsMatteo Piazza, Toni Giorgino, Ivano Azzini, et al.
Biochemical Society Transactions|September 25, 2010
Exploring the LPS/TLR4 signal pathway with small moleculesFrancesco Peri, Matteo Piazza, Valentina Calabrese, et al.
Biochemical Pharmacology|July 6, 2010
The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 bindingMatteo Piazza, Valentina Calabrese, Chiara Baruffa, et al.
Biochemistry|November 26, 2009
Evidence of a specific interaction between new synthetic antisepsis agents and CD14Matteo Piazza, Liping Yu, Athmane Teghanemt, et al.
Innate Immunity|May 18, 2010
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targetsMatteo Piazza, Gaetana Damore, Barbara Costa, et al.
Journal of Medicinal Chemistry|January 24, 2009
Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterizationMatteo Piazza, Clara Rossini, Silvia Della Fiorentina, et al.
Chemical Biology & Drug Design|February 21, 2016
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological PropertiesCarlotta Ciaramelli, Valentina Calabrese, Stefania E Sestito, et al.
Pageof 1